New patent expiration for Merck Sharp drug STEGLUJAN

Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are eight… The post New patent expiration for Merck Sharp drug STEGLUJAN appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog